Brd4-Nutm1 fusion gene initiates NUT carcinoma in vivo

Nut carcinoma (NC) is an aggressive cancer with no effective treatment. The majority (70%) of NUT carcinoma is associated with chromosome translocation events that lead to the formation of a BRD4::NUTM1 fusion gene. However, because the BRD4::NUTM1 gene is unequivocally cytotoxic when ectopically ex...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Zheng, Dejin, Ahmed El Negiry, Luo, Chenxiang, Bendahou, Mohammed Amine, Xie, Liangqi, Bell, Diana, Takahashi, Yoko, Hanna, Ehab, Mias, George I, Tsoi, Mayra F, Gu, Bin
Format Paper
LanguageEnglish
Published Cold Spring Harbor Cold Spring Harbor Laboratory Press 02.01.2024
Subjects
Cancer
Carcinoma
Chromosome translocations
Cytotoxicity
Fusion protein
Genetic engineering
Phenotypes
Tumorigenesis
Tumors
Online AccessGet full text

Cover

More Information
Summary:Nut carcinoma (NC) is an aggressive cancer with no effective treatment. The majority (70%) of NUT carcinoma is associated with chromosome translocation events that lead to the formation of a BRD4::NUTM1 fusion gene. However, because the BRD4::NUTM1 gene is unequivocally cytotoxic when ectopically expressed in cell lines, questions remain on whether the fusion gene can initiate NC. Here, we report the first genetically engineered mouse model (GEMM) for NUT carcinoma recapitulating the human mutation. By stochastically inducing a chromosome translocation mirroring the human event, we demonstrated that the Brd4::Nutm1 fusion gene could induce aggressive carcinomas in mice. The tumors present histopathological and molecular features similar to human NC, with an enrichment of undifferentiated cells. Similar to the reports of human NC incidence, Brd4::Nutm1 can induce NC from a broad range of tissues, demonstrating that its oncogenic potential is not lineage-restricted. The consistent induction of tumors of squamous phenotypes, even from ductal epithelial and mesenchymal tissues, demonstrated a strong reprogramming activity of BRD4::NUTM1. The new mouse model provided a critical preclinical model for NC and opens new opportunities for understanding the oncogenic mechanism and developing new therapies.Competing Interest StatementThe authors have declared no competing interest.Footnotes* We provided a more comprehensive characterization of the Nut carcinoma GEMM, including additional cre drive mediated oncogenesis that demonstrate the oncogenic activity of BRD4::NUTM1 in a broader tissue context, recapitulating human incidence.
DOI:10.1101/2023.07.29.551125